Algernon Pharmaceuticals CEO Christopher J. Moreau to Be Featured on Radius Research's Pitch, Deep Dive and Q&A Webinar on April 16th, 2024 - Algernon Pharmaceuticals (OTC:AGNPF)

VANCOUVER, British Columbia, April 11, 2024 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (the "Company" or "Algernon") (CSE:AGN) (FRANKFURT: AGW0) (OTCQB:AGNPF), is pleased to invite investors and other interested

Related Keywords

United Kingdom ,Canada ,Vancouver ,British Columbia ,Canadian ,British ,Martin Gagel ,Christopherj Moreau ,Algernon Pharmaceuticals ,Company Or Algernon ,Neither The Canadian Securities Exchange ,Radius Research Pitch ,Market Radius Capital Inc ,Market Radius Research ,Canadian Securities Exchange ,Algernon Pharmaceuticals Inc ,Seyltx Inc ,Market Radius ,Deep Dive ,Registration Link ,Radius Research ,Market Radius Capital ,Algernon Neuroscience ,Market Regulator ,